At a glance
- Originator Xenova Group
- Class Antithrombotics; Piperazines
- Mechanism of Action Plasminogen activator inhibitor-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Angina pectoris; Cancer; Thrombosis
Most Recent Events
- 01 Aug 2002 Discontinued - Preclinical for Angina pectoris in Europe (unspecified route)
- 01 Aug 2002 Discontinued - Preclinical for Cancer in Europe (unspecified route)
- 01 Aug 2002 Discontinued - Preclinical for Thrombosis in Europe (unspecified route)